Buscar
-
Striatopallidal cannabinoid type-1 receptors mediate amphetamine-induced sensitization
(2023-10)Document de travail - Pré-publicationLibre acceso -
Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43
(Nature Communications. vol. 14, n° 1, pp. 2303, 2023-04-21)Article de revueLibre acceso -
Out-of-Pocket Expenses in Households of People Living with Obesity in France
(Obesity Facts. vol. 16, n° 6, pp. 606-613, 2023)Article de revueLibre acceso -
Early Administration of the Phytocannabinoid Cannabidivarin Prevents the Neurobehavioral Abnormalities Associated with the Fmr1-KO Mouse Model of Fragile X Syndrome
(Cells. vol. 12, n° 15, pp. 1927, 2023-07-25)Article de revueLibre acceso -
An enquiry to the role of CB1 receptors in neurodegeneration
(Neurobiology of Disease. vol. 184, 2023-08)Article de revueLibre acceso -
Natalizumab Treatment Induces Proinflammatory CD4 T Cells Preferentially in the Integrin β7+ Compartment
(Neurology(R) neuroimmunology & neuroinflammation. vol. 10, n° 6, 2023-09-22)Article de revueLibre acceso -
Lifespan neurodegeneration of the human brain in multiple sclerosis
(Human Brain Mapping. vol. 44, n° 17, pp. 5602-5611, 2023-03-14)Article de revueLibre acceso -
Transcending the amyloid-beta dominance paradigm in Alzheimer's disease: An exploration of behavioural, metabolic, and gut microbiota phenotypes in 5xFAD mice
(Neurobiology of Disease. vol. 187, 2023-10-15)Article de revueLibre acceso -
Mitochondria-targeted melatonin photorelease supports the presence of melatonin MT1 receptors in mitochondria inhibiting respiration
(Cell Chemical Biology. vol. 30, n° 8, pp. 920-932, 2023-08-17)Article de revueLibre acceso -
Improvements in quality of life over 2 years with cladribine tablets in people with relapsing multiple sclerosis: The CLARIFY-MS study
(Multiple Sclerosis Journal. vol. 29, n° 14, pp. 1808-1818, 2023-12)Article de revueLibre acceso